• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors




Robert Unitan, MD

Latest:

Effect of a Patient Panel-Support Tool on Care Delivery

A panel-support tool in a managed care setting improved the percentage of care recommendations met for patients with diabetes mellitus or cardiovascular disease.



Joseph R. Volpicelli, MD, PhD

Latest:

Opioid Analgesic Treated Chronic Pain Patients at Risk for Problematic Use

A large proportion of opioid analgesic treated chronic pain patients exhibited behaviors indicative of potentially problematic opioid use, which significantly affected healthcare costs.



Paul D. Cleary, PhD

Latest:

Impact of Incentives to Improve Care for Primary Care Patients

Multiple factors can impact the effectiveness of financial incentives intended to encourage primary care providers to improve patient experiences.



Joseph O. Jacobson, MD, MSc

Latest:

Lessons From the Front: Designing and Implementing Clinical Pathways by and for Clinicians

As cancer care becomes more complex and more expensive, decision-support algorithms offer a mechanism to define best practice, reduce unwarranted variation, and control costs across growing networks.


Jay M. Margolis, PharmD

Latest:

Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health Plans

Prior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.


Karen A. Monsen, PhD, RN, FAAN

Latest:

Applicability of the Omaha System in Acute Care Nursing for Information Interoperability in the Era of Accountable Care

Complex interventions from hospital settings mapped to Omaha System terms commonly used in community care; demonstrating its potential as a tool for interoperability across settings.


Bikaramjit Mann, MD

Latest:

A Systematic Review of Value-Based Insurance Design in Chronic Diseases

Value-based insurance design for prescription drug coverage increases drug adherence in patients with chronic disease, though their effect on clinical outcomes and health spending remain uncertain.


David Ginosar, MD

Latest:

Care by Cell Phone: Text Messaging for Chronic Disease Management

Cell phone“based text messaging may be used to feasibly support chronic disease management and engagement in diabetes self-care behaviors for some patients.


Emilio Flores, PhD

Latest:

Management of Procalcitonin Test Overuse in an Emergency Department Through a Computer Algorithm

Procalcitonin test demand from the emergency department is growing, necessitating the implementation of strategies to address overuse. Successful interventions must be based on information technology.



Elizabeth Malcolm, MD, MSHS

Latest:

Opportunities to Improve the Value of Outpatient Surgical Care

Outpatient surgeries in the United States account for roughly 7% of annual healthcare expenditures. To exploit substantial opportunities to improve the value of outpatient surgical care, the authors composed an evidence-based care delivery composite for national discussion and pilot testing.


Erika L. Abramson, MD, MS

Latest:

Trending Health Information Technology Adoption Among New York Nursing Homes

This study examines adoption of electronic health records and participation in health information exchange by New York state nursing homes over time.



Fatma M. Shebl, MD, PhD

Latest:

High-Cost, High-Need Patients: The Impact of Reported Penicillin Allergy

A reported penicillin allergy was common and was associated with suboptimal antibiotic choices and increased healthcare utilization in high-cost, high-need patients.



Bret L. Hicken, PhD, MSPH

Latest:

Review of Veterans Health Administration Telemedicine Interventions

A review of exemplary VHA-sponsored telemedicine interventions indicates that telemedicine can efficiently address patient healthcare needs.



Tony Hagen

Latest:

Approvals, Policy Changes Raise Profile of Biosimilars in Canada

At least 8 biosimilars were approved in Canada over the past 12 months, as policy makers made a strong push for biosimilar acceptance, which led to a change in prescribing patterns.






Michael P. Pignone, MD, MPH

Latest:

Leveling the Field: Addressing Health Disparities Through Diabetes Disease Management

A subanalysis of a successful algorithm-driven primary care–based diabetes disease management program examines the relationships among patient characteristics, labor inputs, and improvement in A1C level.



© 2024 MJH Life Sciences
AJMC®
All rights reserved.